Europe — EMA

Oxaliplatina Aurovitas

Oxaliplatin, the active ingredient in Oxaliplatina Aurovitas, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatina Aurovitas, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oxaliplatina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a platinum‑based chemotherapeutic that works … ... .... … … … .... … … … … … … … … … … …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →